Literature DB >> 10939804

Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia.

M Albitar, M Beran, S O'Brien, H Kantarjian, E Frieriech, M Keating, E Estey.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10939804

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Automated multidimensional phenotypic profiling using large public microarray repositories.

Authors:  Min Xu; Wenyuan Li; Gareth M James; Michael R Mehan; Xianghong Jasmine Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-09       Impact factor: 11.205

Review 2.  Recent advances in the diagnosis and classification of myeloid neoplasms--comments on the 2008 WHO classification.

Authors:  C C Yin; L J Medeiros; C E Bueso-Ramos
Journal:  Int J Lab Hematol       Date:  2010-07-07       Impact factor: 2.877

3.  Treatment of acute myeloid leukemia with 20-30% bone marrow blasts.

Authors:  Luca Maurillo; Francesco Buccisano; Maria Ilaria Del Principe; Chiara Sarlo; Luigi Di Caprio; Concetta Ditto; Federica Giannotti; Daniela Nasso; Eleonora Ceresoli; Massimiliano Postorino; Marco Refrigeri; Sergio Amadori; Adriano Venditti
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-06-03       Impact factor: 2.576

4.  Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.

Authors:  Lisa Pleyer; Sonja Burgstaller; Reinhard Stauder; Michael Girschikofsky; Heinz Sill; Konstantin Schlick; Josef Thaler; Britta Halter; Sigrid Machherndl-Spandl; Armin Zebisch; Angelika Pichler; Michael Pfeilstöcker; Eva-Maria Autzinger; Alois Lang; Klaus Geissler; Daniela Voskova; Dietmar Geissler; Wolfgang R Sperr; Sabine Hojas; Inga M Rogulj; Johannes Andel; Richard Greil
Journal:  J Hematol Oncol       Date:  2016-04-16       Impact factor: 17.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.